tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KDNY

Novartis completes acquisition of Chinook Therapeutics
The FlyNovartis completes acquisition of Chinook Therapeutics
1y ago
NVS
KDNY
Wedbush downgrades Chinook Therapeutics to Neutral as acquisition draws closer
PremiumThe Fly
Wedbush downgrades Chinook Therapeutics to Neutral as acquisition draws closer
1y ago
NVS
KDNY
Chinook Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Chinook Therapeutics downgraded to Neutral from Outperform at Wedbush
1y ago
KDNY
Chinook Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Chinook Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
1y ago
KDNY
Chinook announces first patient enrolled in Phase 3 BEYOND study of BION-1301
PremiumThe Fly
Chinook announces first patient enrolled in Phase 3 BEYOND study of BION-1301
1y ago
KDNY
Chinook Therapeutics presents data from CHK-336 Phase 1 trial
PremiumThe FlyChinook Therapeutics presents data from CHK-336 Phase 1 trial
2y ago
KDNY
Chinook Therapeutics downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Chinook Therapeutics downgraded to In Line from Outperform at Evercore ISI
2y ago
KDNY
Chinook Therapeutics downgraded to Hold from Buy at Stifel
Premium
The Fly
Chinook Therapeutics downgraded to Hold from Buy at Stifel
2y ago
KDNY
Chinook Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Chinook Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2y ago
KDNY
Chinook downgraded to Market Perform from Outperform at SVB Securities
PremiumThe Fly
Chinook downgraded to Market Perform from Outperform at SVB Securities
2y ago
KDNY
Lexicon has ‘only un-partnered asset’ in SGLT2i space, says Piper
PremiumThe Fly
Lexicon has ‘only un-partnered asset’ in SGLT2i space, says Piper
2y ago
NVS
KDNY
Chinook Therapeutics downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Chinook Therapeutics downgraded to Neutral from Buy at Guggenheim
2y ago
KDNY
Chinook Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyChinook Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
2y ago
KDNY
Chinook downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Chinook downgraded to Market Perform from Outperform at William Blair
2y ago
NVS
KDNY
KDNY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
KDNY Upcoming Earnings Report: What to Expect?
2y ago
KDNY
Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim
PremiumThe Fly
Chinook Therapeutics price target lowered to $35 from $43 at Guggenheim
2y ago
KDNY
TVTX
TipRanks ‘Perfect 10’ List: These 2 Top-Rated Stocks Could Be Long-Term Winners
PremiumStock Analysis & Ideas
TipRanks ‘Perfect 10’ List: These 2 Top-Rated Stocks Could Be Long-Term Winners
2y ago
IMTX
KDNY
Chinook Therapeutics announces voluntary pause in dosing o CHK-336
PremiumThe Fly
Chinook Therapeutics announces voluntary pause in dosing o CHK-336
2y ago
KDNY
Chinook Therapeutics management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Chinook Therapeutics management to meet virtually with Cantor Fitzgerald
2y ago
KDNY
Chinook Therapeutics management to meet virtually with Cantor Fitzgerald
PremiumThe FlyChinook Therapeutics management to meet virtually with Cantor Fitzgerald
2y ago
KDNY
Chinook Therapeutics management to meet with Piper Sandler
Premium
The Fly
Chinook Therapeutics management to meet with Piper Sandler
2y ago
KDNY
Chinook Therapeutics management to meet with Piper Sandler
Premium
The Fly
Chinook Therapeutics management to meet with Piper Sandler
2y ago
KDNY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >